Published in J Immunol on October 18, 2010
Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders. Blood (2012) 0.77
Human β2-glycoprotein I attenuates mouse intestinal ischemia/reperfusion induced injury and inflammation. Mol Immunol (2012) 0.77
Membrane lipid interactions in intestinal ischemia/reperfusion-induced Injury. Clin Immunol (2014) 0.77
TLR2 modulates antibodies required for intestinal ischemia/reperfusion-induced damage and inflammation. J Immunol (2014) 0.76
Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury. J Immunol (2012) 0.76
The Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion Injury. PLoS One (2016) 0.76
Natural IgM Blockade Limits Infarct Expansion and Left Ventricular Dysfunction in a Swine Myocardial Infarct Model. Circ Cardiovasc Interv (2016) 0.75
Prevention of intestinal ischemia-reperfusion injury in humanized mice. Surgery (2016) 0.75
Phospholipid scramblase 1 is required for β2-glycoprotein I binding in hypoxia and reoxygenation-induced endothelial inflammation. J Leukoc Biol (2015) 0.75
Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg (1970) 5.62
Role of neutrophils in ischemia-reperfusion-induced microvascular injury. Am J Physiol (1987) 2.75
Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med (1996) 2.67
Identification of the target self-antigens in reperfusion injury. J Exp Med (2006) 2.38
Natural antibodies and complement link innate and acquired immunity. Immunol Today (2000) 2.37
Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A (2004) 2.30
Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol (1985) (1999) 2.13
Toll-like receptors in ischemia-reperfusion injury. Shock (2009) 1.92
Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol (1992) 1.84
Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras (2005) 1.59
Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol (2002) 1.58
Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J (1999) 1.58
Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood (2003) 1.45
Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation (1988) 1.39
The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J Immunol (1994) 1.36
Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg (1993) 1.34
Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J Immunol (1993) 1.26
Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. J Immunol (2004) 1.20
Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum (2007) 1.18
Chemical synthesis and characterization of peptides and oligomeric proteins designed to form transmembrane ion channels. Int J Pept Protein Res (1994) 1.15
Complement in ischemia reperfusion injury. Am J Pathol (2003) 1.15
Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of beta2-glycoprotein I in macrophage recognition. J Biol Chem (1997) 1.15
Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. J Immunol (2001) 1.14
Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol (1995) 1.14
Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol (1996) 1.12
Complement inhibition prevents gut ischemia and endothelial cell dysfunction after hemorrhage/resuscitation. Surgery (1998) 1.08
Intestinal ischemia. Gastroenterol Clin North Am (2003) 1.07
TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage. J Leukoc Biol (2009) 1.06
Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation. Ann Thorac Surg (2004) 1.05
C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury. Clin Immunol (2003) 1.04
Complement mediators in ischemia-reperfusion injury. Clin Chim Acta (2006) 1.03
Monoclonal antibodies from NZW x BXSB F1 mice to beta2 glycoprotein I and cardiolipin. Species specificity and charge-dependent binding. J Immunol (1996) 1.00
Human natural IgM can induce ischemia/reperfusion injury in a murine intestinal model. Mol Immunol (2008) 0.98
Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface. Thromb Haemost (1995) 0.98
Ro 60 functions as a receptor for beta(2)-glycoprotein I on apoptotic cells. Arthritis Rheum (2009) 0.97
Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation. Mol Immunol (2006) 0.96
Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome. Lupus (2008) 0.96
High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Ann Rheum Dis (2004) 0.96
Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome. J Rheumatol (1995) 0.96
Activity, disulphide mapping and structural modelling of the fifth domain of human beta 2-glycoprotein I. FEBS Lett (1992) 0.95
Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I. Arthritis Rheum (1998) 0.94
A novel role of gap junction connexin46 protein to protect breast tumors from hypoxia. Int J Cancer (2010) 0.94
Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin Immunol (1999) 0.93
TLR2 is one of the endothelial receptors for beta 2-glycoprotein I. J Immunol (2010) 0.93
Cell-specific regulation of the CD21 gene. Int Immunopharmacol (2001) 0.92
C5 is required for CD49d expression on neutrophils and VCAM expression on vascular endothelial cells following mesenteric ischemia/reperfusion. Clin Immunol (2003) 0.92
Characterization of isoelectric subspecies of asialo-beta 2-glycoprotein I. Biochem J (1989) 0.91
A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice. Lupus (2006) 0.88
Aggregation of beta(2)-glycoprotein I induced by sodium lauryl sulfate and lysophospholipids. Biochemistry (2002) 0.86
Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia/reperfusion in Rag-1(-/-) mice. Autoimmunity (2007) 0.86
Antiphospholipid antibodies: discovery, definitions, detection and disease. Prog Lipid Res (2003) 0.84
Antigenic specificities of antiphospholipid autoantibodies: implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome. Lupus (1996) 0.83
Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion. Biochim Biophys Acta (2010) 0.83
Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus. Rheumatology (Oxford) (2008) 0.82
The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays. Am J Med (1996) 0.82
Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies. Autoimmunity (2005) 0.80
Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies. J Autoimmun (2000) 0.80
beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation. Arthritis Rheum (2009) 0.79
A new player in the antiphospholipid syndrome: the beta 2 glycoprotein I cofactor. Autoimmunity (1992) 0.78
Characterization, expression and evolution of mouse beta 2-glycoprotein I (apolipoprotein H). Biochem Biophys Res Commun (1994) 0.78
Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome. J Immunotoxicol (2008) 0.78
Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting. Pathology (2008) 0.78
An analysis of experimental conditions influencing the anti-beta2-glycoprotein I ELISA assay results. Ann N Y Acad Sci (2007) 0.76
Apolipoprotein oxidation in the absence of lipid peroxidation enhances LDL uptake by macrophages. FEBS Lett (1994) 0.76
Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro. Antimicrob Agents Chemother (2005) 1.33
A dysfunctional tricarboxylic acid cycle enhances fitness of Staphylococcus epidermidis during β-lactam stress. MBio (2013) 1.28
Proteomic and transcriptomic analyses of rigid and membranous cuticles and epidermis from the elytra and hindwings of the red flour beetle, Tribolium castaneum. J Proteome Res (2011) 1.06
Synthesis and initial characterization of FGFR3 transmembrane domain: consequences of sequence modifications. Biochim Biophys Acta (2005) 1.06
Distinct structural elements that direct solution aggregation and membrane assembly in the channel-forming peptide M2GlyR. Biochemistry (2002) 0.99
Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion. Mol Immunol (2010) 0.99
Rubisco activase and wheat productivity under heat-stress conditions. J Exp Bot (2009) 0.99
Formation of rigid, non-flight forewings (elytra) of a beetle requires two major cuticular proteins. PLoS Genet (2012) 0.98
Natural antibodies, autoantibodies and complement activation in tissue injury. Autoimmunity (2006) 0.96
Tribolium castaneum larval gut transcriptome and proteome: A resource for the study of the coleopteran gut. J Proteome Res (2009) 0.94
Peptide nanovesicles formed by the self-assembly of branched amphiphilic peptides. PLoS One (2012) 0.93
Activity and structural comparisons of solution associating and monomeric channel-forming peptides derived from the glycine receptor m2 segment. Biophys J (2004) 0.93
Conformation and environment of channel-forming peptides: a simulation study. Biophys J (2005) 0.93
Identification, RNAi knockdown, and functional analysis of an ejaculate protein that mediates a postmating, prezygotic phenotype in a cricket. PLoS One (2009) 0.92
Redesigning channel-forming peptides: amino acid substitutions that enhance rates of supramolecular self-assembly and raise ion transport activity. Biophys J (2005) 0.92
Effect of the synthetic NC-1059 peptide on diffusion of riboflavin across an intact corneal epithelium. Invest Ophthalmol Vis Sci (2012) 0.92
Cryspovirus: a new genus of protozoan viruses in the family Partitiviridae. Arch Virol (2009) 0.91
LEDGF activation of PKC gamma and gap junction disassembly in lens epithelial cells. Exp Eye Res (2003) 0.88
Channel-forming peptide modulates transepithelial electrical conductance and solute permeability. Am J Physiol Cell Physiol (2004) 0.87
Comparative proteomics uncovers the signature of natural selection acting on the ejaculate proteomes of two cricket species isolated by postmating, prezygotic phenotypes. Mol Biol Evol (2010) 0.86
Biochemical characterization of Anopheles gambiae SRPN6, a malaria parasite invasion marker in mosquitoes. PLoS One (2012) 0.85
Adhesion and structure properties of protein nanomaterials containing hydrophobic and charged amino acids. J Nanosci Nanotechnol (2006) 0.85
Heat-induced accumulation of chloroplast protein synthesis elongation factor, EF-Tu, in winter wheat. J Plant Physiol (2007) 0.82
Mycorrhizal status and diversity of fungal endophytes in roots of common buckwheat (Fagopyrum esculentum) and tartary buckwheat (F. tataricum). Mycorrhiza (2008) 0.81
TLR9 is dispensable for intestinal ischemia/reperfusion-induced tissue damage. Am J Clin Exp Immunol (2012) 0.81
Epithelial barrier modulation by a channel forming peptide. J Membr Biol (2008) 0.80
Evaluation of in vitro and in vivo activity of benzindazole-4,9-quinones against Cryptosporidium parvum. J Antimicrob Chemother (2002) 0.80
Structural characterization of two pore-forming peptides: consequences of introducing a C-terminal tryptophan. Proteins (2010) 0.80
Macrophage-produced IL-12p70 mediates hemorrhage-induced damage in a complement-dependent manner. Shock (2011) 0.80
Immunity to a self-derived, channel-forming peptide in the respiratory tract. Clin Vaccine Immunol (2007) 0.80
Branched oligopeptides form nanocapsules with lipid vesicle characteristics. Langmuir (2013) 0.79
NMR structure and dynamic studies of an anion-binding, channel-forming heptapeptide. J Am Chem Soc (2006) 0.79
NC-1059: a channel-forming peptide that modulates drug delivery across in vitro corneal epithelium. Invest Ophthalmol Vis Sci (2009) 0.79
Hemorrhage-induced intestinal damage is complement-independent in Helicobacter hepaticus-infected mice. Shock (2010) 0.78
CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent. J Immunol (2010) 0.78
Design of 11-residue peptides with unusual biophysical properties: induced secondary structure in the absence of water. Biophys J (2007) 0.78
Conformational changes and catalytic competency of hydrolases adsorbing on fumed silica nanoparticles: I. tertiary structure. Colloids Surf B Biointerfaces (2010) 0.78
Human β2-glycoprotein I attenuates mouse intestinal ischemia/reperfusion induced injury and inflammation. Mol Immunol (2012) 0.77
Macrophage cell lines use CD81 in cell growth regulation. In Vitro Cell Dev Biol Anim (2009) 0.77
Helicobacter infection alters MyD88 and Trif signalling in response to intestinal ischaemia-reperfusion. Exp Physiol (2010) 0.77
Branched amphiphilic cationic oligopeptides form peptiplexes with DNA: a study of their biophysical properties and transfection efficiency. Mol Pharm (2015) 0.77
Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury. J Immunol (2012) 0.76
Conformational changes and catalytic competency of hydrolases adsorbing on fumed silica nanoparticles: II. Secondary structure. Colloids Surf B Biointerfaces (2010) 0.76
Rat jugular catheter model of biofilm-mediated infection. Methods Mol Biol (2014) 0.76
TLR2 Regulates Complement-Mediated Inflammation Induced by Blood Loss During Hemorrhage. Shock (2016) 0.75
Fibrinogen, riboflavin, and UVA to immobilize a corneal flap--molecular mechanisms. Invest Ophthalmol Vis Sci (2012) 0.75
Effect of diaminopropionic acid (Dap) on the biophysical properties of a modified synthetic channel-forming peptide. Mol Pharm (2013) 0.75
On-target derivatization of keratan sulfate oligosaccharides with pyrenebutyric acid hydrazide for MALDI-TOF/TOF-MS. J Mass Spectrom (2008) 0.75
Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor. Vet Ophthalmol (2004) 0.75